REALIZE Gets Real
Hep Talk
Hepatitis C Antiviral Telaprevir Moves Closer to Approval
by Larry Buhl
Researchers in a recent Phase III study are encouraged by the results of a...
HealtheVoices Conference Applications Due January 20, 2019
The HealtheVoices Conference, a three-day event that brings together online advocates from across various health conditions, including HIV/AIDS, provides valuable content, such as tips...
Absorb This!
HIV-related diarrhea is a damaging condition that can greatly affect quality of life, as well as increase the risk of mortality in people living...
Survivor’s Fatigue
What’s Your Damage?” was the name of the arts panel that kicked off the opening night of ACT UP/San Francisco’s reunion gathering commemorating the...
HCV & Underreporting
By the Numbers
While HCV prevalence is down, the rate of morbidity may be going up
by Larry Buhl
New data on the prevalence of hepatitis C...
A Shot in the Dark
Therapeutic Vaccine Research Toward a Functional Cure Shows Promise
by Jeannie Wraight
Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...
Year in Review
What were the top five HCV-related stories of 2012?
by Larry Buhl
There were many important news stories about hepatitis in 2012. In this column we...
Gut Instinct
AIDS Healthcare Foundation Trains a Research Lens on Probiotics
by Chael Needle
"Probiotics” has become a new buzz word in the dairy aisle—at least two brands...
Gateway to Justice
It’s a state with a relatively low prevalence of HIV, but a high number of convictions for HIV non-disclosure and some of the nation’s...
Race to the Hep C Cure
Race to the Cure
Who are the biggest players now in eradicating hepatitis C?
by Larry Buhl
Beyond the implementation of the Affordable Care Act, one of...